Featured White Papers
- 9 critical reasons to automate performance management (SuccessFactors, Inc.)
- The secret to effective, no-hassle performance reviews (SuccessFactors, Inc.)
- The missing link: Driving business results through pay-for-performance (SuccessFactors, Inc.)
Health Care Industry
Industry: Email Alert RSS FeedTravel immunizations
American Family Physician, July 1, 2004 by Vincent Lo Re, III, Stephen J. Gluckman
(20.) Werzberger A, Mensch B, Kuter B, Brown L, Lewis J, Sitrin R, et al. A controlled trial of a formalin-inactivated hepatitis A vaccine in healthy children. N Engl J Med 1992;327:453-7.
(21.) Innis BL, Snitbhan R, Kunasol P, Laorakpongse T, Poopatanakool W, Kozik CA, et al. Protection against hepatitis A by an inactivated vaccine. JAMA 1994;271:1328-34.
(22.) Wolfe MS. Protection of travelers. Clin Infect Dis 1997;25:177-86.
(23.) Clemens R, Safary A, Hepburn A, Roche C, Stanbury WJ, Andre FE. Clinical experience with an inactivated hepatitis A vaccine. J Infect Dis 1995;171(suppl 1):S44-9.
(24.) Update: recommendations to prevent hepatitis B virus transmission--United States. MMWR Morb Mortal Wkly Rep 1999;48:33-4.
(25.) Advice for travelers. Med Lett Drugs Ther 2002; 44(1128):33-8.
(26.) Steffen R. Immunization against hepatitis A and hepatitis B infections. J Travel Med 2001;8(Suppl 1):S9-16.
(27.) Inactivated Japanese encephalitis virus vaccine. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1993;42(RR-1):1-15.
(28.) Hoke CH, Nisalak A, Sangawhipa N, Jatanasen S, Laorakapongse T, Innis BL, et al. Protection against Japanese encephalitis by inactivated vaccines. N Engl J Med 1988;319:608-14.
(29.) Shlim DR, Solomon T. Japanese encephalitis vaccine for travelers: exploring the limits of risk. Clin Infect Dis 2002;35:183-8.
(30.) Typhoid immunization. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1994;43(RR-14):1-7.
(31.) Control and prevention of meningococcal disease: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 1997;46(RR-5):1-10.
(32.) Briggs DJ. Rabies vaccination: protecting vulnerable travelers. Infect Med 2002;19:561-5.
(33.) Wilde H, Briggs DJ, Meslin FX, Hemachudha T, Sitprija V. Rabies update for travel medicine advisors. Clin Infect Dis 2003;37:96-100.
(34). Human rabies prevention--United States, 1999. Recommendations of the Advisory Committee on Immunization Practices (ACIP) [Published correction appears in MMWR Morb Mortal Wkly Rep 2000;49:737]. MMWR Recomm Rep 1999;48(RR-1):1-21.
VINCENT LO RE III, M.D., is a postdoctoral research fellow in the Division of Infectious Diseases at the University of Pennsylvania School of Medicine, Philadelphia, where he received his medical degree. He completed a residency in internal medicine and a fellowship in infectious diseases at the Hospital of the University of Pennsylvania, where he was chief resident.
STEPHEN J. GLUCKMAN, M.D., is a professor of medicine and chief of the Infectious Diseases Clinical Services in the Division of Infectious Diseases at the University of Pennsylvania School of Medicine, Philadelphia. He received his medical degree from Columbia University, New York, N.Y., and a certificate of expertise in international and travel medicine from the American Society of Tropical Medicine and Hygiene.
Address correspondence to Vincent Lo Re III, M.D., Division of Infectious Diseases, University of Pennsylvania School of Medicine, 502 Johnson Pavilion, Philadelphia, PA 19104 (e-mail: vincent.lore@uphs.upenn.edu). Reprints are not available from the authors.
COPYRIGHT 2004 American Academy of Family Physicians
COPYRIGHT 2004 Gale Group